ArticleClinical rheumatology2025
Clinical characterization of malignant lymphoma mimicking IgG4-related disease.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lymphoproliferative Disorders Mimicking Rheumatologic Disease: A Clinical Reasoning Perspective.Current allergy and asthma reports · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo analyze the clinical characteristics of malignant lymphoma that closely resembles IgG4-related disease (IgG4-RD).
methodsThis study retrospectively analysis involving 31 patients who were lymphoma mimicking, IgG4-RD and 50 contemporaneous IgG4-RD patients serving as controls. Lymphoma mimicking IgG4-RD was defined as presenting with masses in the typical sites of IgG4-RD, with or without elevated serum IgG4 levels, and ultimately confirmed to be lymphoma. The clinical data, including the extent of lymph node involvement, maximum diameter of lymph nodes, systemic symptoms, and laboratory parameters were assessed. Student's t-test, the Mann-Whitney test, and the chi-squared test were used to compare the two groups.
resultsFever emerged as a distinctive feature in lymphoma patients. Compared to IgG4-RD, lymphoma patients exhibited a greater extent of lymph node involvement (p < 0.001), larger maximum diameters of lymph nodes (p = 0.007), and higher frequency of enlargement in supraclavicular (41.9% vs 10.0%; p = 0.001), armpit (45.2% vs 16.0%; p = 0.004), retroperitoneal (70.9% vs 10.0%; p < 0.001), and groin lymph nodes (41.9% vs 8.0%; p < 0.001). In contrast, IgG4-RD patients were more likely to show involvement of submandibular gland (58.0% vs 29.0%; p = 0.015) and pancreatic (44.0% vs 9.7%; p = 0.001). Additionally, lymphoma patients presented with higher levels of erythrocyte sedimentation rate (ESR) (p = 0.010), C-reactive protein (CRP) (p < 0.001), and lactate dehydrogenase (LDH) (p = 0.002), along with a higher prevalence of anemia (35.5% vs 4.0%; p < 0.001) and lower albumin levels (p = 0.039), while IgG4-RD patients had higher IgG4/IgG ratio (p < 0.001) and lower complement 3 (C3) (p = 0.009) levels than lymphoma patients.
conclusionAlthough patients with malignant lymphoma and IgG4-RD share some overlapping presentations, they differ significantly in some distinct features, including fever, pattern of lymph node and organ involvement distribution, and some laboratory parameters. Key Points • IgG4-related disease (IgG4-RD) is an immune-mediated disorder characterized by elevated serum IgG4 levels, presenting lymphadenopathy and tumor-like sclerosing lesions in extranodal sites. • Lymphoma, a malignancy that originates from lymphocytes, can present with a variety of clinical manifestations, including painless swelling of lymph nodes and enlargement of different organs. • While patients with malignant lymphoma and IgG4-RD share certain overlapping clinical presentations, they exhibit significant differences in distinct features, including fever, patterns of lymph node and organ involvement, and various laboratory parameters.
Indexed as
Identifiers
40327158What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.